Dark

SGMO
Sangamo Therapeutics, Inc. Common Stock
stock NASDAQ

Market Open

Jan 29, 2026 2:50:24 PM EST

0.5000USD+36.823%(+0.1340)29,040,712

0.4300Bid 0.5700Ask 0.1400Spread

Pre-market

Jan 29, 2026 9:28:30 AM EST

0.4044USD+11.129%(+0.0405)638,747

After-hours

Jan 28, 2026 4:52:30 PM EST

0.3675USD+1.170%(+0.0043)0

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

167.39M

CEO

Alexander Macrae

Headquarters

Brisbane, California, USA

Industry

Biotechnology

Next Earnings

Mar 16, 2026 (45d)

AMGN BMRN SHPG GILD BIIB ALNY PDLI JNJ MRK DWDP XLV

SGMO Stats

Avg. Vol. 10 Day

4,505,458

Avg. Vol. 30 Day

4,201,551

Employees

209

Market Cap

167,389,184

Shares Out.

336,494,489

On/Off Exchange

31%/69%

6 Month Beta

2.16

1 Year Beta

1.23

2 Year Beta

1.57

3 Year Beta

1.60

52 Week Low

0.36

52 Week High

1.40

SMA50

0.43

SMA200

0.54

1 Week

+24.83%

1 Month

+21.75%

3 Month

-14.23%

6 Month

-12.71%

1 Year

-55.98%

2 Year

+11.44%

5 Year

-96.36%

Profile

for sangamo therapeutics, science is a means to develop new medicines with the potential to transform the lives of patients living with serious genetic diseases. our scientists are leaders in the discovery, research and development of technologies enabling gene-based therapeutic development. currently we are conducting clinical trials, including the first ever in vivo human genome editing studies. to learn more about sangamo, visit the our website at www.sangamo.com.

SGMO Stock Summary

Sangamo Therapeutics, Inc. Common Stock (NASDAQ:SGMO) stock price today is $0.5000, and today's volume is 29,040,712. SGMO is up 36.823% today. The 30 day average volume is 4,201,551. SGMO market cap is 167.39M with 336,494,489 shares outstanding.